$BIVIW
Biovie Inc.
Nasdaq · Pharmaceutical Preparations · Carson City, NV
BIVIW chart
What traders are saying about $BIVIW
Latest postsBiovie Inc. news
- BioVie Stockholders Approve Directors, Auditor, and Equity Plan
TipRanks ·
- BioVie shareholders approve director elections and equity plan at annual meeting
Investing.com ·
- Form 8K Biovie Inc For: 10 November By Investing.com
Investing.com Canada ·
- BIVI: BioVie Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders
Quantisnow ·
- BioVie to present additional Parkinson’s drug data at international conference
proactiveinvestors.com ·
- BioVie Inc. (BIVI) stock price, news, quote and history
Yahoo Finance UK ·
- BioVie Invited to Present Data on Bezisterim in Parkinson’s Disease at the AD/PD2027 International Conference on Alzheimer's & Parkinson’s Diseases
Yahoo Finance ·
- In a 57-patient Parkinson’s trial, 25% on the drug had meaningful gains on a combined health score, vs. 4% on placebo.
Stock Titan ·
- BioVie identifies two Long COVID patient groups with distinct responses to bezisterim
proactiveinvestors.com ·
- BioVie presents Long COVID biomarker data at NIH workshop
StreetInsider ·
- BioVie Presents New Biomarker Data from the ADDRESS-LC Trial of Bezisterim in Long COVID at the NIH RECOVER-TLC Third Annual Workshop
Yahoo Finance ·
- Biovie (BIVI) Stock Price, Chart & Analysis
www.debelegger.nl ·
Biovie Inc. key financials
| USD | 2026 | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Net income | -$22.1M | -$17.5M | -$32.1M | -$50.3M |
| Diluted EPS | $-3.05 | $-12.12 | $-73.05 | $-15.47 |
| Total assets (year end) | – | $22.5M | $25.7M | $21.5M |
| Cash and equivalents (year end) | – | $20.5M | $24.4M | $20.2M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
- 8-KCURRENT REPORT
- 10-QFORM 10-Q FOR PERIOD ENDING SEPTEMBER 30, 2026
- 8-KCURRENT REPORT
- DEF 14ADEF 14A
- 8-KCURRENT REPORT
- 10-KFORM 10-K FOR PERIOD ENDED JUNE 30, 2026
- 8-KCURRENT REPORT
- S-1FORM S-1 REGISTRATION STATEMENT
- 10-QFORM 10-Q FOR PERIOD ENDING MARCH 31, 2026
- 10-QFORM 10-Q FOR PERIOD ENDING DECEMBER 31, 2025
- 8-KCURRENT REPORT
- 8-KCURRENT REPORT
About Biovie Inc.
- Ticker
- BIVIW (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- Carson City, NV
- Incorporated in
- NV
- Fiscal year end
- June 30
- SEC CIK
- 1580149
- Former names
- NANOANTIBIOTICS, INC.
Frequently asked questions
What exchange is Biovie Inc. listed on?
Biovie Inc. trades on the Nasdaq under the ticker symbol BIVIW.
What industry is Biovie Inc. in?
Biovie Inc. is classified by the SEC under "Pharmaceutical Preparations".
Where is Biovie Inc. headquartered?
Biovie Inc.'s business address on file with the SEC is in Carson City, NV.
When does Biovie Inc.'s fiscal year end?
Biovie Inc.'s fiscal year ends on June 30.